APOE and COVID-19: The pooled results showed that ApoE gene polymorphism (ε4 carrier genotypes VS non-ε4 carrier genotypes) is associated with a high risk of COVID-19 (P = 0.0003, OR = 1.44, 95% CI 1.18–1.76) (Fig. 2A).